Monitoring Agency Report for the quarter ended March 31, 2025.
SIGACHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sigachi Industries filed two Monitoring Agency reports for Q4 FY25 — one from Kotak Mahindra Bank for the original IPO (₹125.43 crore raised in Nov 2021) and one from CARE Ratings for the Convertible Share Warrants private placement (₹286.45 crore, Jul-Aug 2023). On the IPO side, ₹57.40 crore has been fully used for microcrystalline cellulose (MCC) capacity expansion at Dahej and Jhagadia, but the ₹32.30 crore earmarked for Croscarmellose Sodium (CCS) manufacturing is still untouched — the project has been shifted from Kurnool, Andhra Pradesh to Dahej SEZ with shareholder approval, and the deadline extended from FY2024 to FY2026. Major government approvals (CTE, GIDC, electricity, SEIAA environmental clearance on April 16, 2025) are now in place and site work has begun. On the warrants side, only ₹217.82 crore of the targeted ₹286.45 crore was actually received, with ₹68.63 crore still pending from warrant holders, and 41% (₹56.77 crore) of the envisaged promoter contribution (₹135.72 crore) remains uninfused — promoters have pledged additional shares to bridge this gap, raising their personal debt. ₹86.51 crore has been deployed towards the API facility so far, while Working Capital and General Corporate Purpose heads are marked as completed.
Routine compliance filing, but it surfaces two things shareholders should track: a 24-month delay on the CCS project from the IPO, and a real funding gap in the warrants issue (₹68.63 crore shortfall plus promoter under-contribution), which could slow the planned API expansion. The promoter share pledging to meet their own commitment signals some balance-sheet stress at the promoter level, though core operations appear to be on track.